A dozen plaintiffs filed a complaint against Duke University and administrators, researchers and doctors there, claiming they engaged in fraudulent behavior and neglect when they registered cancer patients in a clinical trial compromised by incorrect data. The lawsuit, filed Wednesday before a North Carolina court is 14 months after a scandal erupted at Duke who finally exposed the extent of testing problems in July 2010, Duke oncologist Anil Potti, whose job was the trial center, admitted he had embellished his resume and later resigned.
The complainants - cancer patients who were in the tests and the families of trial participants who are no longer alive - Duke officials say the long knew that the work Potti and Joseph Nevins , a cancer geneticist who was director of the Center for Applied Genomics at Duke & Technology, was "very suspicious", but launched clinical trials based on it anyway. (A series of co-author pair of documents was retracted during the past year.) "In May 07, after being placed on notice of the flawed science behind its cancer studies as mentioned above, Duke University and / or Duhs [Duke University Health System] nevertheless began their first clinical trial, "the lawsuit says. the trial assigned patients lung cancer to certain treatments based on gene expression profiles now discredited Potti and Nevins said that they had identified in tumor cells.
the prosecution is scathing in his assessment of how Duke handled the growing concern expressed by foreigners, especially the two biostatistician at MD Anderson Cancer Center in Houston, Texas.
the applicants argue that the answer of the Duke "to the charge of the invalid and fraudulent science was deceptive, misleading and fraudulent conduct to protect its reputation and interests of owners. .. rather than to protect the safety of patients involved in clinical trials. "The trial continues: This" reduces the likelihood that the plaintiffs to survive his / her cancer or the likelihood of experiencing a positive response to chemotherapy "
The plaintiffs want at least $ 30,000 each in. damages and a jury trial. Duke University said it can not comment on active litigation. Meanwhile, the Institute of medicine studies how gene expression profiles are used in medicine and hope conclude the project next year.
0 Komentar